June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Geographic atrophy in AMD - prognostic factors based on long-term follow-up
Author Affiliations & Notes
  • Katja B Hatz
    Vista Klinik AG, Binningen, Switzerland
    Universitat Basel, Basel, Basel-Stadt, Switzerland
  • Laura Hoffmann
    Vista Klinik AG, Binningen, Switzerland
  • Luca Cedro
    Vista Klinik AG, Binningen, Switzerland
  • Footnotes
    Commercial Relationships   Katja Hatz Roche, Novartis, Bayer, Allergan, Code F (Financial Support); Laura Hoffmann None; Luca Cedro None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 338 – F0169. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Katja B Hatz, Laura Hoffmann, Luca Cedro; Geographic atrophy in AMD - prognostic factors based on long-term follow-up. Invest. Ophthalmol. Vis. Sci. 2022;63(7):338 – F0169.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : So far, the natural course of geographic atrophy (GA) progression in age-related macular degeneration (AMD) has primarily been investigated by fundus photography and fundus autofluorescence (FAF) imaging. The aim of this long-term retrospective, observational clinical study was to show the enlargement rate (ER) of GA, defined as complete retinal pigment epithelium and outer retinal atrophy (cRORA) and to find predictors of progression.

Methods : All patients available in the database of Vista Eye Clinic Binningen, Switzerland, with follow-up of at least 24 months and existing GA in at least one eye, regardless of neovascular AMD (nAMD) being present initially or in the course of disease, were included. SD-OCT and FAF evaluations were performed according to a standardized protocol. The cRORA area ER (mm2/yr), the cRORA square root area ER (mm/yr), the FAF GA area and the condition of the outer retina (inner-/outer segment line (IS/OS) and external limiting membrane (ELM) disruption scores) were determined.

Results : 210 eyes of 133 patient (65% females) were included. Mean follow-up time was 4.0±2.3 (range 2-10) years. 109 (52%) eyes were classified as primary or secondary nAMD, 101 (48%) as exclusively dry AMD. The primary lesion was unifocal in 151 (72%) and multifocal in 59 (28%) eyes. A strong correlation was observed between the area of cRORA (SD-OCT) and the FAF GA area (r= 0.925; p<0.001). Mean ER was 1.44±1.6 mm2/yr and mean square root ER 0.29±0.19 mm/yr. There was no significant difference in mean ER between eyes without (dry AMD) and with intravitreal anti-VEGF injections (nAMD) (0.3±0.19 mm/yr vs. 0.28±0.20 mm/yr; p=0.466). Eyes with a multifocal GA pattern at baseline had a significantly higher mean ER compared to eyes with a unifocal pattern (0.34±0.19 mm/yr vs. 0.27±1.19 mm/yr; p=0.008). There were moderate significant correlations between ELM and IS/OS disruption scores and visual acuity at baseline, 5 and 7 years (all r values ca. -0.5; p<0.001). In multivariate regression analysis, a scattered cRORA pattern at baseline (p=0.022) and a smaller baseline lesion size (p=0.036) were associated with a higher mean ER.

Conclusions : SD-OCT evaluated cRORA area might serve as a GA parameter comparable to traditional FAF measurement. The dispersion pattern and baseline lesion size might be predictors of ER, whereas anti-VEGF treatment seems not to be associated with ER.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×